Growing Prevalence of Infectious Diseases Anticipated to Augur Market Growth
According to the CDC, in the U.S., hospital-acquired infections (HAI) account for over 1.5 million infections & nearly 95,000 associated deaths per year. Molecular diagnostic is critical in the field of infectious disease testing as it provides rapid & successful results. The rising prevalence of infectious diseases & hospital-acquired infections is therefore expected to fuel molecular diagnostics market across the North American region from 2021 to 2031.

Which Factors are Fueling North America Molecular Diagnostics Market Growth?

  • Growing Geriatric Population Base
  • Increase in Demand for Point-of-Care Facilities
  • Growing Prevalence of Target Diseases Such as Genetic, CVDs, and Neurological Diseases
  • Introduction of Technologically Advanced Products

Which Factors are Restraining Growth?

  • High Prices of Molecular Diagnostics Tests
  • Presence of Ambiguous Regulatory Framework to Impede Market Growth

Technological Advancements to Boost Market Growth
According to Visiongain analysis, advancements in technology is projected to boost North American molecular diagnostics industry growth as they provide greater accuracy and are cost-effective. The market is likely to be guided by the launch of MinION, an affordable and compact sequencer that supplies users in small peripheral laboratories and point of care facilities. Also, high demand for over-the-counter diagnostics is expected to help drive market growth in this area. Furthermore, some of the key factors such as advanced cancer diagnostic testing coupled with growing demand for genetic testing is expected to fuel market growth further through 2031.

UNIQUE COVID-19 VARIATIONS– only available in this report are dedicated analysis of 4 different rebound scenarios of how the market will develop – no matter how COVID-19 affects the economy.

How do prominent players strengthen their position throughout the world?
You must read this newly updated report if you are involved in this sector. The report from Visiongain shows you potential revenues up to 2031, evaluate information, trends, opportunities and business outlooks.

Discover how to stay ahead
Our 350+ page report provides 500+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall North American market and country level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing North America Molecular Diagnostics Market. See how to exploit the opportunities.

Forecasts to 2031 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  •  Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), SWOT Analysis, PEST Analysis, Porter’s Analysis, product profiles and commercial developments.

Discover sales predictions for the North American market and submarkets

Technology
Polymerase Chain Reaction

  • Multiplex PCR
  • Other PCR

In Situ Hybridization
Isothermal Nucleic Acid Amplification Technology
Chips and Microarrays
Mass Spectrometry
Sequencing
Transcription Mediated Amplification
Others

Application

  • Oncology
  • Breast Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Kidney Cancer
  • Liver Cancer
  • Blood Cancer
  • Lung Cancer
  • Other Cancer

Pharmacogenomics

Infectious Diseases

  • Methicillin-Resistant Staphylococcus Aureus
  • Clostridium Difficile
  • Vancomycin-Resistant Enterococci
  • Carbapenem-Resistant Bacteria
  • Flu
  • Respiratory Syncytial Virus
  • Candida
  • Tuberculosis and Drug-Resistant TBA
  • Meningitis
  • Gastrointestinal Panel Testing
  • Chlamydia
  • Gonorrhea
  • HIV
  • Hepatitis C
  • Hepatitis B
  • Other Infectious Diseases

Genetic Testing

  • Newborn Screening
  • Predictive and Presymptomatic Testing
  •  Other Genetic Testing

Neurological Disease

  • Cardiovascular Diseases
  • Microbiology
  • Others

Product

  • Instruments
  • Reagents

Test Location

  • Point-of-Care
  • Over the Counter
  • Central Laboratories

In addition to the revenue predictions for the overall North American market and segments, you will also find revenue forecasts for country by segments as well:

U.S. Molecular Diagnostics Market

  • Revenue Forecasts by Technology
  • Revenue Forecasts by Application
  • Revenue Forecasts by Product
  • Revenue Forecasts by Test Location

Canada Molecular Diagnostics Market

  • Revenue Forecasts by Technology
  • Revenue Forecasts by Application
  • Revenue Forecasts by Product
  • Revenue Forecasts by Test Location